Zoetis Investor Rebalance
Massachusetts Financial Sells 95% Zoetis Stake as Institutional Investors Realign Positions
Key Points
Massachusetts Financial Services Co. MA reduced its Zoetis stake by 95.7% in the second quarter, ending with 18,655 shares worth about $1.341 million after selling 416,742 shares.
Norges Bank earmarked a new Zoetis stake in the fourth quarter, valued at approximately $734.4 million, highlighting continued large-sum institutional involvement.
Other major existing holders expanded or shifted sizeable stakes in Zoetis in the fourth quarter, including Vanguard Group increasing by 12.9% to 47,780,974 shares (roughly $6.01 billion) and J. Stern & Co. LLP jumping by about 12,431% to 24,069,492 shares (roughly $3.03 billion).
Fox Run Management L.L.C disclosed a new Zoetis stake of 29,511 shares valued at about $2.12 million, representing roughly 0.4% of its portfolio and ranking Zoetis as its 19th largest holding.
During the period, brokerages issued mixed-to-cautious updates on Zoetis: JPMorgan cut its price target from $130 to $115 while keeping an overweight rating; Wall Street Zen downgraded from buy to hold; Zacks Research moved from hold to strong sell; Barclays cut its target from $136 to $85 and assigned an equal-weight rating (with Citi also lowering its target to $96 while maintaining a buy).
Massachusetts Financial Services Co. slashed its Zoetis stake by 95.7% in the second quarter, selling 416,742 shares and leaving the firm with just 18,655 shares worth about $1.34 million, according to Watchlist News. The dramatic exit stands in sharp contrast to a wave of smaller funds rushing to buy into the animal health giant.
While one of the stock's major holders was heading for the exit, newer buyers were lining up. Qsemble Capital Management, Fox Run Management, and Everstar Asset Management all opened fresh positions in Zoetis during the same quarter. Overall institutional ownership in the company sits at around 92.8%.
Massachusetts Financial Services Makes Massive Exit from ZTS
Massachusetts Financial Services dumped nearly all of its Zoetis position in Q2. The firm sold 416,742 shares, leaving just 18,655 shares on its books. At current prices, that remaining stake is worth roughly $1.34 million — a shadow of its former holding, according to Watchlist News.
The move is one of the most dramatic single-quarter cuts seen among Zoetis's institutional backers. No public reason was given for the sell-off. It raises questions about near-term confidence in the stock, even as other funds are moving in the opposite direction.
New Buyers Rush In as Smaller Funds Open Fresh Positions
Three new institutional buyers entered Zoetis in Q2. Qsemble Capital Management picked up 30,208 shares worth about $2.17 million. Fox Run Management bought 29,511 shares for around $2.12 million, making Zoetis its 19th largest holding. Everstar Asset Management added 11,025 shares for roughly $792,000, according to Watchlist News.
Other funds also added to existing positions. Root Financial Partners, Elyxium Wealth, and Wellington Group all increased or built stakes during the period. The broad-based buying shows many smaller funds still see value in Zoetis, even as bigger players scale back.
Vanguard and Norges Bank Commit Billions to Zoetis
Not all large investors are backing away. Norges Bank opened a brand-new position in Zoetis in Q4, valued at approximately $734.4 million. Vanguard Group also expanded its stake by 12.9%, bringing its total to 47,780,974 shares worth about $6.01 billion. These are not small bets.
Perhaps the most striking move came from J. Stern and Co., which grew its Zoetis position by about 12,431% in Q4, reaching 24,069,492 shares worth roughly $3.03 billion. That kind of jump suggests a major strategic decision to build a core holding in the company.
Analysts Cut Targets but Some Still See Upside for ZTS
Analyst views on Zoetis grew more cautious during the period. JPMorgan trimmed its price target from $130 to $115, though it kept an overweight rating. Barclays cut its target more sharply, dropping from $136 to $85, and assigned an equal-weight rating. Citi also lowered its target to $96 but held onto its buy rating.
The downgrades did not stop there. Wall Street Zen moved Zoetis from buy to hold. Zacks Research went further, shifting its rating from hold to strong sell. The mixed signals from Wall Street mirror the divided behavior among institutional investors — some loading up, others walking away.
Sentiment
Mostly PositivePublishers
10
Articles
15
Reach
25
